Missing/wrong data?
Log in to edit
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study
scientific article published on 25 November 2019
Author/s
author: Tarik Asselah, Stanislas Pol, Eric Nguyen-Khac
Work details
Publication date
November 25, 2019
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.